Each year, the TIDES conference scientific agenda includes 150+ of the industry's top scientists to present the latest science and industry updates across the entire spectrum from discovery, preclinical, clinical development through CMC, Manufacturing and commercialization of therapeutics and vaccines for oligos, peptides, mRNA and genome editing products.
In this ebook, we look at the milestones and challenges encountered by today’s leading researchers in the journey of targeted deliveries in the oligonucleotide, peptide, and mRNA industries. The next pages include whitepapers and presentation overviews from the latest TIDES events, with insights from AsahiKasei, Ohio State University, MIT, Aruna bio, and more.
